Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
Times Cited: 1838
Times Cited: 1838
Times Cited
Times Co-cited
Similarity
Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
44
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
37
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
32
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration.
Pravin U Dugel, Adrian Koh, Yuichiro Ogura, Glenn J Jaffe, Ursula Schmidt-Erfurth, David M Brown, Andre V Gomes, James Warburton, Andreas Weichselberger, Frank G Holz. Ophthalmology 2020
Pravin U Dugel, Adrian Koh, Yuichiro Ogura, Glenn J Jaffe, Ursula Schmidt-Erfurth, David M Brown, Andre V Gomes, James Warburton, Andreas Weichselberger, Frank G Holz. Ophthalmology 2020
24
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
Daniel F Martin, Maureen G Maguire, Stuart L Fine, Gui-shuang Ying, Glenn J Jaffe, Juan E Grunwald, Cynthia Toth, Maryann Redford, Frederick L Ferris. Ophthalmology 2012
20
Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
Wan Ling Wong, Xinyi Su, Xiang Li, Chui Ming G Cheung, Ronald Klein, Ching-Yu Cheng, Tien Yin Wong. Lancet Glob Health 2014
16
Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP).
Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang. Ophthalmology 2013
Soraya Rofagha, Robert B Bhisitkul, David S Boyer, SriniVas R Sadda, Kang Zhang. Ophthalmology 2013
15
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials.
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
Maureen G Maguire, Daniel F Martin, Gui-Shuang Ying, Glenn J Jaffe, Ebenezer Daniel, Juan E Grunwald, Cynthia A Toth, Frederick L Ferris, Stuart L Fine. Ophthalmology 2016
14
Multi-country real-life experience of anti-vascular endothelial growth factor therapy for wet age-related macular degeneration.
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
Frank G Holz, Ramin Tadayoni, Stephen Beatty, Alan Berger, Matteo G Cereda, Rafael Cortez, Carel B Hoyng, Philip Hykin, Giovanni Staurenghi, Stephanie Heldner,[...]. Br J Ophthalmol 2015
14
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
14
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Sarah Wordsworth, Barnaby C Reeves. Ophthalmology 2012
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Sarah Wordsworth, Barnaby C Reeves. Ophthalmology 2012
13
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.
Carl D Regillo, David M Brown, Prema Abraham, Huibin Yue, Tsontcho Ianchulev, Susan Schneider, Naveed Shams. Am J Ophthalmol 2008
Carl D Regillo, David M Brown, Prema Abraham, Huibin Yue, Tsontcho Ianchulev, Susan Schneider, Naveed Shams. Am J Ophthalmol 2008
12
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
12
Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Brandon G Busbee, Allen C Ho, David M Brown, Jeffrey S Heier, Ivan J Suñer, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2013
Brandon G Busbee, Allen C Ho, David M Brown, Jeffrey S Heier, Ivan J Suñer, Zhengrong Li, Roman G Rubio, Phillip Lai. Ophthalmology 2013
12
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen: FLUID Study 24-Month Results.
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
Robyn H Guymer, Caroline M Markey, Ian L McAllister, Mark C Gillies, Alex P Hunyor, Jennifer J Arnold. Ophthalmology 2019
11
Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
Ursula Schmidt-Erfurth, Victor Chong, Anat Loewenstein, Michael Larsen, Eric Souied, Reinier Schlingemann, Bora Eldem, Jordi Monés, Gisbert Richard, Francesco Bandello. Br J Ophthalmol 2014
10
Prospective Trial of Treat-and-Extend versus Monthly Dosing for Neovascular Age-Related Macular Degeneration: TREX-AMD 1-Year Results.
Charles C Wykoff, Daniel E Croft, David M Brown, Rui Wang, John F Payne, Lloyd Clark, Nizar Saleh Abdelfattah, SriniVas R Sadda. Ophthalmology 2015
Charles C Wykoff, Daniel E Croft, David M Brown, Rui Wang, John F Payne, Lloyd Clark, Nizar Saleh Abdelfattah, SriniVas R Sadda. Ophthalmology 2015
10
Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study.
Rufino Silva, András Berta, Michael Larsen, Wayne Macfadden, Chrystel Feller, Jordi Monés. Ophthalmology 2018
Rufino Silva, András Berta, Michael Larsen, Wayne Macfadden, Chrystel Feller, Jordi Monés. Ophthalmology 2018
10
Age-related macular degeneration.
Paul Mitchell, Gerald Liew, Bamini Gopinath, Tien Y Wong. Lancet 2018
Paul Mitchell, Gerald Liew, Bamini Gopinath, Tien Y Wong. Lancet 2018
9
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial.
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
Usha Chakravarthy, Simon P Harding, Chris A Rogers, Susan M Downes, Andrew J Lotery, Lucy A Culliford, Barnaby C Reeves. Lancet 2013
9
Comparison of ranibizumab and bevacizumab for neovascular age-related macular degeneration according to LUCAS treat-and-extend protocol.
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
Karina Berg, Terje R Pedersen, Leiv Sandvik, Ragnheiður Bragadóttir. Ophthalmology 2015
9
Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
Ursula Schmidt-Erfurth, Peter K Kaiser, Jean-François Korobelnik, David M Brown, Victor Chong, Quan Dong Nguyen, Allen C Ho, Yuichiro Ogura, Christian Simader, Glenn J Jaffe,[...]. Ophthalmology 2014
9
Associations of Variation in Retinal Thickness With Visual Acuity and Anatomic Outcomes in Eyes With Neovascular Age-Related Macular Degeneration Lesions Treated With Anti-Vascular Endothelial Growth Factor Agents.
Rebecca N Evans, Barnaby C Reeves, Maureen G Maguire, Daniel F Martin, Alyson Muldrew, Tunde Peto, Chris Rogers, Usha Chakravarthy. JAMA Ophthalmol 2020
Rebecca N Evans, Barnaby C Reeves, Maureen G Maguire, Daniel F Martin, Alyson Muldrew, Tunde Peto, Chris Rogers, Usha Chakravarthy. JAMA Ophthalmol 2020
25
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial.
Laurent Kodjikian, Eric H Souied, Gérard Mimoun, Martine Mauget-Faÿsse, Francine Behar-Cohen, Evelyne Decullier, Laure Huot, Gilles Aulagner. Ophthalmology 2013
Laurent Kodjikian, Eric H Souied, Gérard Mimoun, Martine Mauget-Faÿsse, Francine Behar-Cohen, Evelyne Decullier, Laure Huot, Gilles Aulagner. Ophthalmology 2013
9
Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study.
Ursula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, Jean-François Korobelnik, Reinier O Schlingemann, Ruth Axer-Siegel, Peter Wiedemann, Christian Simader, Margarita Gekkieva, Andreas Weichselberger. Ophthalmology 2011
Ursula Schmidt-Erfurth, Bora Eldem, Robyn Guymer, Jean-François Korobelnik, Reinier O Schlingemann, Ruth Axer-Siegel, Peter Wiedemann, Christian Simader, Margarita Gekkieva, Andreas Weichselberger. Ophthalmology 2011
8
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sumit Sharma, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Maureen G Maguire, Gui-Shuang Ying, Jiayan Huang, Daniel F Martin, Glenn J Jaffe. Ophthalmology 2016
Sumit Sharma, Cynthia A Toth, Ebenezer Daniel, Juan E Grunwald, Maureen G Maguire, Gui-Shuang Ying, Jiayan Huang, Daniel F Martin, Glenn J Jaffe. Ophthalmology 2016
8
Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data: Consensus on Neovascular Age-Related Macular Degeneration Nomenclature Study Group.
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
Richard F Spaide, Glenn J Jaffe, David Sarraf, K Bailey Freund, Srinivas R Sadda, Giovanni Staurenghi, Nadia K Waheed, Usha Chakravarthy, Philip J Rosenfeld, Frank G Holz,[...]. Ophthalmology 2020
8
Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion-Related Events with Brolucizumab: Post Hoc Review of HAWK and HARRIER.
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, Ramin Tadayoni, Thomas A Albini, Peter K Kaiser, Frank G Holz, Jean-Francois Korobelnik, Ivana K Kim, Christian Pruente,[...]. Ophthalmology 2021
Jordi Monés, Sunil K Srivastava, Glenn J Jaffe, Ramin Tadayoni, Thomas A Albini, Peter K Kaiser, Frank G Holz, Jean-Francois Korobelnik, Ivana K Kim, Christian Pruente,[...]. Ophthalmology 2021
11
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials.
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, Gui-Shuang Ying, Wei Pan, Glenn J Jaffe, Cynthia A Toth, Stephanie A Hagstrom, Maureen G Maguire, Daniel F Martin. Ophthalmology 2017
Juan E Grunwald, Maxwell Pistilli, Ebenezer Daniel, Gui-Shuang Ying, Wei Pan, Glenn J Jaffe, Cynthia A Toth, Stephanie A Hagstrom, Maureen G Maguire, Daniel F Martin. Ophthalmology 2017
7
Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors.
Hemal Mehta, Adnan Tufail, Vincent Daien, Aaron Y Lee, Vuong Nguyen, Mehmet Ozturk, Daniel Barthelmes, Mark C Gillies. Prog Retin Eye Res 2018
Hemal Mehta, Adnan Tufail, Vincent Daien, Aaron Y Lee, Vuong Nguyen, Mehmet Ozturk, Daniel Barthelmes, Mark C Gillies. Prog Retin Eye Res 2018
7
Treat and extend versus pro re nata regimens of ranibizumab and aflibercept in neovascular age-related macular degeneration: a comparative study.
Michèle Augsburger, Gian-Marco Sarra, Pascal Imesch. Graefes Arch Clin Exp Ophthalmol 2019
Michèle Augsburger, Gian-Marco Sarra, Pascal Imesch. Graefes Arch Clin Exp Ophthalmol 2019
15
Effect of Ranibizumab and Aflibercept on Best-Corrected Visual Acuity in Treat-and-Extend for Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial.
Mark C Gillies, Alex P Hunyor, Jennifer J Arnold, Robyn H Guymer, Sebastian Wolf, Paul Ng, Francois L Pecheur, Ian L McAllister. JAMA Ophthalmol 2019
Mark C Gillies, Alex P Hunyor, Jennifer J Arnold, Robyn H Guymer, Sebastian Wolf, Paul Ng, Francois L Pecheur, Ian L McAllister. JAMA Ophthalmol 2019
10
A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
Ursula Schmidt-Erfurth, Sebastian M Waldstein. Prog Retin Eye Res 2016
7
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration: A Randomized Controlled Study.
Frank G Holz, Pravin U Dugel, Georges Weissgerber, Robin Hamilton, Rufino Silva, Francesco Bandello, Michael Larsen, Andreas Weichselberger, Andreas Wenzel, Anne Schmidt,[...]. Ophthalmology 2016
Frank G Holz, Pravin U Dugel, Georges Weissgerber, Robin Hamilton, Rufino Silva, Francesco Bandello, Michael Larsen, Andreas Weichselberger, Andreas Wenzel, Anne Schmidt,[...]. Ophthalmology 2016
10
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
Caroline R Baumal, Richard F Spaide, Lejla Vajzovic, K Bailey Freund, Scott D Walter, Vishak John, Ryan Rich, Nauman Chaudhry, Rohit R Lakhanpal, Patrick R Oellers,[...]. Ophthalmology 2020
Caroline R Baumal, Richard F Spaide, Lejla Vajzovic, K Bailey Freund, Scott D Walter, Vishak John, Ryan Rich, Nauman Chaudhry, Rohit R Lakhanpal, Patrick R Oellers,[...]. Ophthalmology 2020
7
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
7
Age-related macular degeneration.
Laurence S Lim, Paul Mitchell, Johanna M Seddon, Frank G Holz, Tien Y Wong. Lancet 2012
Laurence S Lim, Paul Mitchell, Johanna M Seddon, Frank G Holz, Tien Y Wong. Lancet 2012
6
Innovative therapies for neovascular age-related macular degeneration.
Hasenin Al-Khersan, Rehan M Hussain, Thomas A Ciulla, Pravin U Dugel. Expert Opin Pharmacother 2019
Hasenin Al-Khersan, Rehan M Hussain, Thomas A Ciulla, Pravin U Dugel. Expert Opin Pharmacother 2019
13
HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration.
Michael A Singer, Carl C Awh, SriniVas Sadda, William R Freeman, Andrew N Antoszyk, Pamela Wong, Lisa Tuomi. Ophthalmology 2012
Michael A Singer, Carl C Awh, SriniVas Sadda, William R Freeman, Andrew N Antoszyk, Pamela Wong, Lisa Tuomi. Ophthalmology 2012
6
Efficacy and Safety of Abicipar in Neovascular Age-Related Macular Degeneration: 52-Week Results of Phase 3 Randomized Controlled Study.
Derek Kunimoto, Young Hee Yoon, Charles C Wykoff, Andrew Chang, Rahul N Khurana, Raj K Maturi, Hansjürgen Agostini, Eric Souied, David R Chow, Andrew J Lotery,[...]. Ophthalmology 2020
Derek Kunimoto, Young Hee Yoon, Charles C Wykoff, Andrew Chang, Rahul N Khurana, Raj K Maturi, Hansjürgen Agostini, Eric Souied, David R Chow, Andrew J Lotery,[...]. Ophthalmology 2020
16
Occlusive Retinal Vasculitis Following Intravitreal Brolucizumab.
Andre J Witkin, Paul Hahn, Timothy G Murray, J Fernando Arevalo, Kevin J Blinder, Netan Choudhry, Geoff G Emerson, Roger A Goldberg, Stephen J Kim, Joel Pearlman,[...]. J Vitreoretin Dis 2020
Andre J Witkin, Paul Hahn, Timothy G Murray, J Fernando Arevalo, Kevin J Blinder, Netan Choudhry, Geoff G Emerson, Roger A Goldberg, Stephen J Kim, Joel Pearlman,[...]. J Vitreoretin Dis 2020
9
Brolucizumab Versus Aflibercept in Participants with Neovascular Age-Related Macular Degeneration: A Randomized Trial.
Pravin U Dugel, Glenn J Jaffe, Peter Sallstig, James Warburton, Andreas Weichselberger, Mark Wieland, Lawrence Singerman. Ophthalmology 2017
Pravin U Dugel, Glenn J Jaffe, Peter Sallstig, James Warburton, Andreas Weichselberger, Mark Wieland, Lawrence Singerman. Ophthalmology 2017
6
Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes.
Thomas A Ciulla, Rehan M Hussain, John S Pollack, David F Williams. Ophthalmol Retina 2020
Thomas A Ciulla, Rehan M Hussain, John S Pollack, David F Williams. Ophthalmol Retina 2020
12
Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set.
A Lotery, R Griner, A Ferreira, F Milnes, P Dugel. Eye (Lond) 2017
A Lotery, R Griner, A Ferreira, F Milnes, P Dugel. Eye (Lond) 2017
12
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial.
Arshad M Khanani, Sunil S Patel, Philip J Ferrone, Aaron Osborne, Jayashree Sahni, Susanna Grzeschik, Karen Basu, Jason S Ehrlich, Zdenka Haskova, Pravin U Dugel. JAMA Ophthalmol 2020
Arshad M Khanani, Sunil S Patel, Philip J Ferrone, Aaron Osborne, Jayashree Sahni, Susanna Grzeschik, Karen Basu, Jason S Ehrlich, Zdenka Haskova, Pravin U Dugel. JAMA Ophthalmol 2020
13
Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The AVENUE Phase 2 Randomized Clinical Trial.
Jayashree Sahni, Pravin U Dugel, Sunil S Patel, Mark E Chittum, Brian Berger, Marta Del Valle Rubido, Shamil Sadikhov, Piotr Szczesny, Dietmar Schwab, Everson Nogoceke,[...]. JAMA Ophthalmol 2020
Jayashree Sahni, Pravin U Dugel, Sunil S Patel, Mark E Chittum, Brian Berger, Marta Del Valle Rubido, Shamil Sadikhov, Piotr Szczesny, Dietmar Schwab, Everson Nogoceke,[...]. JAMA Ophthalmol 2020
27
IMPLICATION OF RECURRENT OR RETAINED FLUID ON OPTICAL COHERENCE TOMOGRAPHY FOR VISUAL ACUITY DURING ACTIVE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH A TREAT AND EXTEND PROTOCOL.
Sanjeewa S Wickremasinghe, Vyshnavi Janakan, Sukhpal S Sandhu, Fakir M Amirul-Islam, Farshad Abedi, Robyn H Guymer. Retina 2016
Sanjeewa S Wickremasinghe, Vyshnavi Janakan, Sukhpal S Sandhu, Fakir M Amirul-Islam, Farshad Abedi, Robyn H Guymer. Retina 2016
14
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik, Barbara S Hawkins. Cochrane Database Syst Rev 2014
Sharon D Solomon, Kristina Lindsley, Satyanarayana S Vedula, Magdalena G Krzystolik, Barbara S Hawkins. Cochrane Database Syst Rev 2014
5
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis.
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
Seth R Flaxman, Rupert R A Bourne, Serge Resnikoff, Peter Ackland, Tasanee Braithwaite, Maria V Cicinelli, Aditi Das, Jost B Jonas, Jill Keeffe, John H Kempen,[...]. Lancet Glob Health 2017
5
Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results.
Michael Larsen, Ursula Schmidt-Erfurth, Paolo Lanzetta, Sebastian Wolf, Christian Simader, Erika Tokaji, Stefan Pilz, Annemarie Weisberger. Ophthalmology 2012
Michael Larsen, Ursula Schmidt-Erfurth, Paolo Lanzetta, Sebastian Wolf, Christian Simader, Erika Tokaji, Stefan Pilz, Annemarie Weisberger. Ophthalmology 2012
5
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.